Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Johnson & Johnson

http://www.jnj.com

Latest From Johnson & Johnson

J&J Gets Into The Anti-TSLP Game With Proteologix Buyout

The privately held biotech will bring J&J a pair of bispecific antibodies expected to target multiple pathologic pathways in atopic dermatitis and asthma.

M & A Business Strategies

Development Versus Dealmaking: How To Obtain A Blockbuster

Most of the companies with blockbuster drugs approved over the past decade oversaw their clinical development internally. Lilly holds the lead with eight blockbusters developed in-house.

Companies Deals

Takeda Gets A Try-Before-You-Buy Option In Alzheimer’s Immunotherapy

The Japanese company will await imaging results to see if AC Immune’s candidate ACI-24.060 can help prevent or remove plaques before finalizing the deal.

Companies Clinical Trials

The Life Of A Blockbuster

The industry’s top-selling drugs generate billions in revenues each year. Scrip analyzed data on nearly 200 blockbuster drugs to see which are forecast to make the most at peak and over a 14-year time horizon.

Launches Business Strategies
See All

Company Information

  • Industry
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Abiomed, Inc.
    • Acclarent Inc.
    • Actelion Pharmaceuticals Ltd.
    • AdvanceCOR GmbH
    • ALZA Corporation
    • Alios BioPharma, Inc.
    • Animas Corporation
    • Aragon Pharmaceuticals, Inc.
    • Auris Health, Inc.
    • Auris Surgical Robotics
    • BeneVir Biopharm, Inc.
    • BioMedical Enterprises, Inc.
    • Biosense Webster, Inc.
    • Calibra Medical, Inc.
    • Centyrex Internal Venture
    • Cilag AG
    • Cerenovus
    • Codman & Shurtleff, Inc
    • Coherex Medical, Inc.
    • Conor Medsystems, Inc.
    • Cordis Webster, Inc.
    • CorImmun GmbH
    • Cougar Biotechnology, Inc.
    • Covagen AG
    • Crucell N.V.
    • DePuy Mitek, Inc.
    • DePuy Orthopaedics, Inc.
    • DePuy Synthes, Inc.
    • Ensure Medical
    • Ethicon, Inc.
    • FemRx Inc.
    • Flexible Stenting Solutions, Inc.
    • Gynecare, Inc.
    • Hansen Medical, Inc.
    • Innovative Surgical Solutions, LLC
    • Interventional Spine, Inc.
    • Janssen Biotech, Inc. (formerly Centocor Ortho Biotech Inc.)
    • Janssen Diagnostics
    • Janssen Pharmaceuticals
    • Janssen Vaccines & Prevention B.V.
    • JointPoint, Inc.
    • LifeScan, Inc.
    • Medical Enterprises Distribution, LLC
    • Medos International SARL
    • Megadyne Medical Products, Inc.
    • Mentor Corporation
    • Micrus Endovascular Corporation
    • Molsaic Internal Venture
    • Momenta Pharmaceuticals, Inc.
    • NeoStrata Company, Inc.
    • Neuravi Limited
    • NeuWave Medical, Inc.
    • Novira Therapeutics
    • Omrix Biopharmaceuticals, Inc.
    • Ortho Biotech Products, L.P.
    • Ortho-McNeil, Inc.
    • Orthotaxy
    • Peninsula Pharmaceuticals, Inc.
    • Pulsar Vascular Inc
    • RespiVert Ltd.
    • Scios, Inc.
    • Selected Nerve Stimulation Internal Ventures
    • Sentio, LLC
    • Sequus Pharmaceuticals
    • Stem Cell Internal Venture
    • Synthes, Inc.
    • Tibotec
    • Torax Medical, Inc.
    • Triage Medical, Inc.
    • Verb Surgical Inc.
    • Veridex
    • Vigor Sub, Inc.
    • Vistakon
    • XO1 Limited
    • TARIS Biomedical LLC
    • Verb Surgical, Inc.
UsernamePublicRestriction

Register